The U.S. China Economic & Security Review Commission heard from witnesses about keeping auto tariffs on China, and more incentives for manufacturing to reshore.
A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded the reintroduction of bipartisan National Critical Capabilities Defense Act by U.S. Representatives Rosa DeLauro
House Committee hears from witnesses who call for better trade enforcement, and keeping tariffs. Meanwhile, de minimis trade rule in the crosshairs again.
Boosting Domestic Solar Manufacturing Would Gut Greenhouse Gas Emissions by 30% WASHINGTON — A recent study by Cornell University researchers confirms that reshoring the solar
A new report by the Government Accountability Office highlights the need for revamped trade deals. But missing from the discussion is the case for more local supply chains.
Can the U.S. really bring manufacturing home? A McKinsey study shows that existing concentration of some supply chains will make it hard. Here’s what needs to be done.